Hereditary haemochromatosis;L'hémochromatose héréditaire

Presse Medicale

Volumn 32, Issue 36, 2003, Pages 1716-1724

  Bismuth, Michael ^a,b   Aguilar Martinez, Patricia ^a   Michel, Henri ^a  

^a HÔPITAL SAINT ELOI   (France)

^b Hôpital Saint Élol   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ALCOHOL LIVER DISEASE; ARTHRALGIA; ARTHROPATHY; BIOACCUMULATION; BLOOD DISEASE; BLOOD TRANSFUSION; CANCER RISK; CAUSE OF DEATH; CLINICAL FEATURE; DELIVERY; DIABETES MELLITUS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE COURSE; DYSPNEA; FERRITIN BLOOD LEVEL; FRANCE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HEART DISEASE; HEART FAILURE; HEMOCHROMATOSIS; HETEROZYGOTE; HFE1 GENE; HOMOZYGOTE; HUMAN; INCIDENCE; IRON ABSORPTION; IRON INTAKE; LIVER CIRRHOSIS; LIVER LEVEL; MAINTENANCE THERAPY; MENSTRUATION; METABOLIC DISORDER; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PREGNANCY; PROGNOSIS; REVIEW; SEXUAL DYSFUNCTION; VIRUS HEPATITIS;

FEMALE; FERRITINS; HEMOCHROMATOSIS; HUMANS; MALE; MUTATION; PREVALENCE; TRANSFERRIN;

EID: 0242642781     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Adams PC, Brissot P, Powell LW. EASL International Consensus Conference on Hemochromatosis. J Hepatol 2000; 33: 485-504.
2. ème édition. Paris. Baillère, 1865,672.
3. Troisier M. Diabète sucré. Bull Soc Anat. Paris 1871: 16: 231.
4. Von Recklinghausen FD. Uber Hämochromatose. Heidelberg. Tagebl. Versamml. Natur. Arzte 1889; 62: 324.
5. Sheldon JH. in Haemochromatosis. Oxford University Press, London, 1935.
6. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976; 17: 332-4.
7. Simon M, Bourel M. Hérédité de l'hé mochromatose idiopathique: démonstration de la transmission récessive et mise en évidence du gène responsable porté par le chromosome 6. Gastroenterol Clin Biol 1978; 2: 573-7
8. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet, 1996; 13: 399-408.
9. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000; 4: 183-98.
10. ème ed Médecine. Sciences Flammarion 2002; 1379: 92.
11. Powell LW, Yap TR. Hemochromatosis. Clin Liver Dis 2000; 4: 211-28.
12. Agence nationale d'accréditation et d'évaluation en santé. Evaluation clinique et économique de l'hé mochromatose génétique en France. Anaes/service évaluation des technologies économiques. Juin 1999.
13. Jouanolle AM, Fergelot P, Raoul ML et al. Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis? Ann Genet 1998; 41: 195-8.
14. Rochette J, Capron D, Capron JP, Julier C. Screening for hereditary hemochromatosis. Am J Gastroenterol 2000; 95: 1368-9.
15. Aguilar-Martinez P, Becker F, Picot M et al. Prevalence of HFE mutations in people from North Africa living in southern France. Br J Haematol 2001; 114: 914-16.
16. Deugnier Y, Jouanolle AM, Chaperon J et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol 2002; 118: 1170-8.
17. Pointon JJ, Viprakasit V, Miles KL et al. Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload small star, filled. Blood Cells Mol Dis 2003: 30: 302-6.
18. Aguilar-Martinez P, Biron C, Blanc F et al. Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease? Blood Cells Mol and Dis, 1997; 23: 269-76.
19. Jouanolle AM, Gandon G, Jezequel P et al. Haemochromatosis and HLA H. Nat Genet 1996; 14: 251-2.
20. Aguilar-Martinez P, Bismuth M, Picot MC et al. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001; 48: 836-42.
21. Restagno G, Gomez AM, Sbaiz L et al. A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. Genet Test 2000; 4: 177-81.
22. Roth MP, Giraldo P, Hariti G et al. Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics 1997; 46: 222-5.
23. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8.
24. Deugnier Y, Jouanolle AM, Chaperon J et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol 2002; 118: 1170-8.
25. Beutler E, Felitti VJ, Koziol JA, Ho NS, Gelbart T. Penetrance of 845 A (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet 2002; 359: 211-18.
26. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997; 127: 105-10.
27. Bulaj ZJ, Ajioka RS, Phillips JD et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2001; 344: 1477-8.
28. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-24.
29. Ryan F, Vaughan J. HFE mutation analysis in a normal Irish Population. Br J Biomed Sci 2000; 57: 315-16.
30. Mc Cune CA, AL-Jader LN, May A et al. Hereditary hemochromatosis; only 1% of adul HFE C282Y homozygotes in south Wales have a clinical diagnosis of iron overload. Hum Genet 2002; 111: 538-43.
31. Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metal-transporter (DMT-1.NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 1999; 353: 2120-3.
32. Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues? Blood Cells Mol Dis 2003; 30: 288-97.
33. Feder JN, Penny DM, Irrinki A et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 95: 1472-7.
34. Lebron JA, West AP Jr, Bjorkman PJ. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol 1999; 294: 239-45.
35. Pigeon C, Ilyin G, Courselaud B et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 7811-19.
36. Nicolas G, Bennoun M, Porteu A et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99: 4596-601.
37. Nicolas G, Bennoun M, Devaux I et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001; 98: 8780-5.
38. Nicolas G, Viatte L, Lou DQ et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003: 34: 97-101.
39. Bridle KR, Frazer DM, Wilkins SJ et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003; 361: 669-73.
40. De Seze S, Hubault A, Weltling J, Kahn MF, Solnica J. Arthropathies des hémochromatoses (hémochromatoses et chondrocalcinoses articulaires). Leur place dans le cadre des arthropathies métaboliques. Rev Rhum Mal Osteoartic 1964; 31: 479-85.
41. Pawlotsky Y. Hémochromatose génétique: arthropathie et fonction parathyroïdienne. Presse Med 1993; 22: 1988-90.
42. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemochromatosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882-8.
43. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002; 122: 281-9.
44. Deugnier Y, Guyader D, Crantoc K et al. Primary liver cancer in genetic hemochromatosis: a clinical pathological and pathogenic study of 54 cases. Gastroenterology 1993; 104: 228-34.
45. Campbell S, George DK, Robb SD et al. The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease. Heart 2003; 89: 1023-6.
46. Wilkinson H. Haemochromatosis associated with arthritis and hypopituitarism. Ann Clin Biochem 1996; 33: 171-3.
47. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: metabolism MR findings and clinical importance. Radiology 1996; 199: 13-22.
48. Camaschella C, Roetto A, De Gobbi M. Genetic haemochromatosis: genes and mutations associated with iron loading. Best Pract Res Clin Haematol 2002; 15: 261-76. Review.
49. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997; 349: 95-7.
50. Larrey D. De la stéatose hépatique de l'obèse à la cirrhose, en l'absence d'intoxication alcoolique. Presse Med 2003; 32: 512-18.
51. Deugnier Y, Mendler MH, Moirand R. Une nouvelle entité: l'hépatosidérose dysmétabolique. Presse Med 2000; 13; 29: 949-51.
52. Whittington CA, Kowdley KV. Review article: haemochromatosis. Aliment Pharmacol Ther 2002; 16: 1963-75.
53. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis. Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
54. Fargion S, Fracanzani AL, Romano R et al. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload. J Hepatol 1996; 24: 564-9.
55. Dereure O, Aguilar-Martinez P, Bessis D et al. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France. Br J Dermatol 2001; 144: 533-9.
56. Tavill AS. Diagnosis and management of hemochromatosis. AASLD Practice Guidelines. Hepatology 2001; 33: 1321-8.
57. Brandhagen DJ. Liver transplantation for hereditary hemochromatosis. Liver Transpl 2001; 7: 663-72.